Search research articles
Contact Us
Filters
Showing results (121-130 of 280) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Effect of food on the pharmacokinetic behavior of the potent oral taxane BMS-275183
Linda E Bröker, Manual Valdivieso, Mary Jo Pilat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2012
Accelerating cancer therapy development: the importance of combination strategies and collaboration. Summary of an Institute of Medicine workshop
Patricia M LoRusso, Renzo Canetta, John A Wagner, et al.
Breast Cancer Research : BCR
|
March 17, 2016
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
Ian E Krop, Shanu Modi, Patricia M LoRusso, et al.
International Journal of Transgender Health
|
April 25, 2025
"<i>The third table where I would sit comfortably</i>": narratives of nonbinary identity routes
B Di Giannantonio, K Milanese, M Mirabella, et al.
Journal of Geriatric Oncology
|
April 20, 2011
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience
Syed F Zafar, Lance K Heilbrun, Prakash Vishnu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting
Navid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Investigational New Drugs
|
January 8, 2014
Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
Carolyn D Britten, Alex A Adjei, Robert Millham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways
Z Ding, R E Parchment, P M LoRusso, et al.
Investigational New Drugs
|
January 1, 1996
Preclinical antitumor activity of CI-994
P M LoRusso, L Demchik, B Foster, et al.
Leukemia & Lymphoma
|
August 23, 2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood
M S Felice, E Hammermuller, M T De Dávila, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 280) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Effect of food on the pharmacokinetic behavior of the potent oral taxane BMS-275183
Linda E Bröker, Manual Valdivieso, Mary Jo Pilat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2012
Accelerating cancer therapy development: the importance of combination strategies and collaboration. Summary of an Institute of Medicine workshop
Patricia M LoRusso, Renzo Canetta, John A Wagner, et al.
Breast Cancer Research : BCR
|
March 17, 2016
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
Ian E Krop, Shanu Modi, Patricia M LoRusso, et al.
International Journal of Transgender Health
|
April 25, 2025
"<i>The third table where I would sit comfortably</i>": narratives of nonbinary identity routes
B Di Giannantonio, K Milanese, M Mirabella, et al.
Journal of Geriatric Oncology
|
April 20, 2011
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience
Syed F Zafar, Lance K Heilbrun, Prakash Vishnu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting
Navid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Investigational New Drugs
|
January 8, 2014
Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
Carolyn D Britten, Alex A Adjei, Robert Millham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways
Z Ding, R E Parchment, P M LoRusso, et al.
Investigational New Drugs
|
January 1, 1996
Preclinical antitumor activity of CI-994
P M LoRusso, L Demchik, B Foster, et al.
Leukemia & Lymphoma
|
August 23, 2000
Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood
M S Felice, E Hammermuller, M T De Dávila, et al.
Page
of 28